mesopeel® MD

mesopeel® MD

peeling medical SOLUTIONS

Multi-acid technology backed by results

A new generation of combined peels with chemo exfoliating agents rigorously selected to treat the main skin conditions while achieving an optimal efficacy and safety profile in the practice.

certified safety and quality

optimal balance between power and safety for the main indications in the practice.

MD complex

formulas that combine chemical exfoliants with a transversal complex with regenerative action.

efficacy demonstrated in studies

strong clinical evidence with immediate effects and progressive results.

versatile and adaptable solutions

versatile and adjustable tool that is essential for optimising multiple medical-aesthetic procedures.

what is mesopeel® MD?

mesopeel® MD is an innovative range of chemical peels designed exclusively for doctors specialising in dermatology and aesthetic medicine.
Solutions that present an optimum balance between potency and safety through advanced formulations that combine rigorously selected chemo-exfoliating agents with a regenerating cross-complex with proven efficacy in in vitro and ex vivo studies.

Versatile, modular solutions that combine safety, certified pharmaceutical quality and solid clinical evidence with immediate effects and progressive results.

indication-specific medical peels

Exponential and personalised results for all indications

peels aging

  • mesopeel® MD periocular

    Antiaging peel indicated to treat signs of aging in the periocular area.

    mesopeel® MD

    periocular

    PEELING PROFESSIONAL SOLUTIONS

    Treatment area face
    Type of skin all
    format 50 ml
    View product
  • mesopeel® MD retiflash

    Provides an immediate glow effect. Revitalises the tone and provides luminosity, attenuating imperfections.

    mesopeel® MD

    retiflash

    PEELING PROFESSIONAL SOLUTIONS

    Treatment area face
    Type of skin all
    format 50 ml
    View product
  • mesopeel® MD phenTCA

    Antiaging TCA (trichloroacetic acid) peel indicated to treat signs of moderate to severe skin aging.

    mesopeel® MD

    phenTCA

    PEELING PROFESSIONAL SOLUTIONS

    Treatment area face
    Type of skin all
    format 50 ml
    View product
  • mesopeel® MD oxyage

    Retexturising peel that attenuates superficial skin imperfections. Unifies skin tone and texture.

    mesopeel® MD

    oxyage

    PEELING PROFESSIONAL SOLUTIONS

    Treatment area face
    Type of skin all
    format 50 ml
    View product

peels pigmentation

  • mesopeel® MD melanostop tranex

    Depigmentation peel that acts by regulating melanogenesis, eliminating superficial melanin.

    mesopeel® MD

    melanostop tranex

    PEELING PROFESSIONAL SOLUTIONS

    Treatment area face
    Type of skin all
    format 50 ml
    View product
  • mesopeel® MD melanoplus touch

    Depigmentation peel for focal use that acts on excess melanin and regulates its production.

    mesopeel® MD

    melanoplus touch

    PEELING PROFESSIONAL SOLUTIONS

    Treatment area face
    Type of skin all
    format 50 ml
    View product

peels oily and acne-prone skin

  • mesopeel® MD mandelic 30%

    Mandelic acid peel. Thick, oily, seborrhoeic skin and/or pigmented skin.

    mesopeel® MD

    mandelic 30%

    PEELING PROFESSIONAL SOLUTIONS

    Treatment area face
    Type of skin oily
    format 50 ml
    View product
  • mesopeel® MD salicylic 20%

    Salicylic acid peel with potent keratolytic and sebum-regulating effect. Oily, acne-prone and/or seborrhoeic skins.

    mesopeel® MD

    salicylic 20%

    PEELING PROFESSIONAL SOLUTIONS

    Treatment area face
    Type of skin oily
    format 50 ml
    View product
  • mesopeel® MD blemiskin

    Peel with keratolytic, comedolytic, anti-inflammatory, antibacterial and seboregulating effect.

    mesopeel® MD

    blemiskin

    PEELING PROFESSIONAL SOLUTIONS

    Treatment area face
    Type of skin oily
    format 50 ml
    View product

peels sensitivity

  • mesopeel® MD azelan rx

    Peel with keratolytic and antibacterial action. Reduces reactive skin manifestations by soothing and relieving the skin.

    mesopeel® MD

    azelan rx

    PEELING PROFESSIONAL SOLUTIONS

    Treatment area face
    Type of skin sensitive
    format 50 ml
    View product
  • mesopeel® MD lactic  30%

    Lactic chemical peel. Ideal for sensitive, dry, thin and/or devitalised skin. High skin tolerance, moisturising effect.

    mesopeel® MD

    lactic 30%

    PEELING PROFESSIONAL SOLUTIONS

    Treatment area face
    Type of skin sensitive
    format 50 ml
    View product

I am an aesthetic professional and I want to offer the treatment in my consultation

efficacy endorsed by science

The power of the new mesopeel® MD formulas is reinforced by an exclusive regenerating and repairing action that complements the controlled aggression of the chemical exfoliants for fast and intensive skin recovery.

Common transversal complex:

MD complex

Regeneration, repair, restructuring

arginine

Regenerative, Restorative

An essential amino acid that stimulates the synthesis of structural proteins, promoting cell regeneration and tissue repair.

shikimic acid

Regenerating, Sebum-regulating

Natural organic compound with regenerative action. Inhibits cellular senescence through epigenetic mechanisms and balances the production of sebum.

caffeic acid

Antioxidant

Powerful molecule with an antioxidant, anti-inflammatory and regenerative action

see efficacy studies

peel application (pH=3)

Degradation of the epidermis.

control

acidic solution (pH 3)

incorporation MD complex

Tissue repair: epidermal restructuring and regeneration.

acidic solution (pH 3)

acidic solution (pH 3) + MD complex

application of UV radiation

Degradation of the epidermis.

control

UV radiation

incorporation MD complex

Tissue repair: epidermal restructuring and regeneration.

UV radiation

UV radiation UV radiation + MD complex

INF490. UB. Report on antiaging efficacy in reconstituted epidermis treated with shikimic acid, caffeic acid and arginine. Biotechnology Unit. mesoestetic Pharma Group S.L. 2022.